GETINGE Aktie

 

STOCKHOLM (dpa-AFX) - Swedish medical technology company Getinge AB (GNGBF, GETI-B.ST) on Tuesday reported higher net profit in its fourth quarter, despite weak net sales. Order intake also was lo......

Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

STOCKHOLM (dpa-AFX) - Getinge AB (GETI-B.ST) released earnings for its fourth quarter that Increases, from the same period last yearThe company's bottom line came in at SEK868 million, or SEK3.19 ......

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

GOTHENBURG, Sweden, Jan. 27, 2026 /PRNewswire/ -- "We succeeded in growing organically, delivering a record-breaking fourth quarter and organic growth at the upper end of our forecast, 4.9% for the full year," says Mattias Perjos, President & CEO at Getinge. Higher demand for consumables......

“We succeeded in growing organically, delivering a record-breaking fourth quarter and organic growth at the upper end of our forecast, 4.9% for the full year,” says Mattias Perjos, President & CEO at Getinge. Higher demand for consumables for ECLS-therapy in the quarter and in Acute Care Therapies contributed to Getinge's performance. Sales were also strong in Transplant Care and ventilators. Surgical Workflows continued to strengthen its market-leading position in operating tables and enters 2026 with robust order bookings. In general, sales are more volatile between quarters for Life...

Company fueled by strong 2025 customer momentumAUSTIN, Texas--(BUSINESS WIRE)--Planview®, the leading platform for Strategic Portfolio Management (SPM) and Digital Product Development (DPD), today announced strong 2025 momentum, driven by significant customer growth, AI innovation, and industry recognition throughout the year. Additionally, Planview enters 2026 with new CEO Matt Zilli at the helm and an updated leadership team to accelerate its AI-first strategy. New Logo and Customer Momentum in 2025 Key customer wins and expansions across Financial Services, Insurance, Healthcare, Technology, Retail, and more have driven Planview's continued profitable growth. In 2025, the company added 274 net new customers; notable customers who selected or expanded their footprint with Planview in 2025 included: Currys Group, DHL, DTCC, EDF Renewables, Farmacia Guadalajara, Fisher & Paykel Healthcare, FIS, Garrett Motion, General Mills, Getinge Sterilization, Global Payments, Harman Connected Services, HCSC, Huntin...

Getinge will issue its Year-End Report 2025 on January 27, 2026, at 08.00 a.m. CET, followed by a conference call at 10.00 a.m. CET, hosted by Mattias Perjos, President & CEO, and Agneta Palmér, CFO. Fund managers, analysts and media are invited to participate in the conference call. To participate via teleconference, please register via this link (https://events.inderes.com/getinge/q4-report-2025/dial-in). After registration, you will be provided with telephone numbers and a conference ID to access the conference. You can ask questions verbally via the telephone conference. During the...

Getinge is unveiling Automatiq, a new family of next generation automated solutions designed to help Central Sterile Supply Departments (CSSDs) achieve safer, more consistent and less labor-intensive sterile reprocessing. Automatiq seamlessly combines smart robotics, intelligent conveyor systems and advanced software to optimize sterile reprocessing and enhance workflow efficiency at every step. [image] CSSDs play a vital role in infection prevention and represent one of the most precise and physically demanding processes in the hospital. During traditional manual processes, CSSD...

The Nomination Committee of Getinge AB (publ) has decided to propose to the Annual General Meeting 2026 that the Meeting elects Camilla Sylvest as a new member of the Board of Directors. The Nomination Committee also informs that the current Board member Malin Persson, who has served since 2014, has announced that she will not be available for re-election in 2026. Camilla Sylvest has more than 28 years of experience at Novo Nordisk A/S, most recently serving eight years as Executive Vice President, Commercial Strategy and Corporate Affairs, and as a member of the executive management team....

Partnership combines SteriPro's off-site reprocessing expertise with Getinge's equipment, automation, and digital workflow solutions to support safer, more scalable surgical services. TORONTO, Nov. 25, 2025 /PRNewswire/ - SteriPro International Inc., Canada's leading provider of......

Today, Getinge and SteriPro International Inc. announced a new strategic partnership that reinforces safer workflows and a scalable model for the future of surgical services within Sterile Processing departments across North America. [image] The unique partnership brings together two complementary strengths: Getinge's proven leadership in sterile processing equipment, automation, and digital workflow solutions, and SteriPro's deep expertise in off-site reprocessing operations. Together, Getinge and SteriPro look to raise quality, increase transparency, and steer meaningful cost...

Getinge introduces a new version of its trusted Solsus 66 Steam Sterilizer – originally launched in 2020 – designed to meet the evolving needs of Central Sterile Supply Departments (CSSDs). [image] Sterile reprocessing is essential to safe and efficient healthcare. Hospitals face increasing pressure to deliver high-quality care while managing costs and space. Getinge´s Solsus 66 helps CSSDs meet these demands. Built on robust technology with over 20 years of heritage, it has become a reliable partner in sterile reprocessing. The new version retains its proven performance while introducing...

Getinge today launches Aquadis 44, its latest washer-disinfector designed to minimize utility use and lower operating costs. This innovative model helps healthcare providers decrease their environmental impact while ensuring reliable performance and ease of use. [image] Hospitals are under growing pressure to reduce their environmental footprint without compromising the quality of care. Getinge's latest washer-disinfector Aquadis 44 responds to this challenge with a combination of low total cost of ownership, improved ergonomics and patent-pending innovations – including adaptive water...

Getinge is advancing efficient cleanroom operations in the biopharma industry by integrating a new open and flexible visualization system in its new generation cGMP washers and sterilizers. [image] SIMATIC WinCC Unified, Siemens' latest open interface, offers a unified solution for effortless integration of both Getinge washers and sterilizers - delivering efficiency and ease of use. “Meeting the digitalization challenges in the pharmaceutical industry is one of our priorities. The integration of one common easy-to-use interface for controlling and monitoring all Getinge washers and...

STOCKHOLM (dpa-AFX) - Getinge AB (GETI-B.ST), a medtech company, on Tuesday reported a profit before tax of SEK 789 million for the third quarter, a sharp increase from SEK 32 million in the same ......

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

GOTHENBURG, Sweden, Oct. 21, 2025 /PRNewswire/ -- "We demonstrated strength in the third quarter with significant organic growth, improved profitability and cash flow despite impacts from tariffs and negative currency effects," says Mattias Perjos, President & CEO, Getinge. The medtech......

“We demonstrated strength in the third quarter with significant organic growth, improved profitability and cash flow despite impacts from tariffs and negative currency effects," says Mattias Perjos, President & CEO, Getinge. The medtech company's net sales increased organically by 9,5% while order intake rose by 4,7% organically. Acute Care Therapies continued to meet the higher demand for ventilators, in the wake of an ongoing market consolidation. Order intake and sales of ECLS consumables were also significant. Both Life Science and Surgical Workflows set sales records for the third...

Getinge's Advanta™ V12 is now approved for major bridging indications, marking a milestone in complex aortic aneurysm treatment. [image] Today, Getinge announces that its Advanta™ V12 Covered Stent System has received CE Mark approval under the European Union Medical Device Regulation (EU MDR) for use as a bridging stent in fenestrated endovascular aneurysm repair (FEVAR), branched endovascular aneurysm repair (BEVAR), and iliac branch device (IBD) aneurysmal repair. This landmark approval offers physicians a trusted, on-label solution backed by over two decades of clinical use. Advanta...